Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vet J ; 208: 38-43, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26639833

RESUMO

The pharmacokinetics and pharmacodynamics (PK/PD) of the angiotensin-converting enzyme inhibitor (ACEI) ramiprilat after intravenous (IV) and oral (PO) administration of ramipril have not been evaluated in horses. This study was designed to establish PK profiles for ramipril and ramiprilat as well as to determine the effects of ramiprilat on serum angiotensin converting enzyme (ACE) and to select the most appropriate ramipril dose that suppresses ACE activity. Six healthy horses in a cross-over design received IV ramipril 0.050 mg/kg, PO at a dose of 0 (placebo), and 0.050, 0.10, 0.20, 0.40 and 0.80 mg/kg ramipril. Blood pressures were measured and blood samples obtained at different times. Serum ramipril and ramiprilat concentrations and serum ACE activity were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and spectrophotometry, respectively. Systemic bioavailability of ramiprilat after PO ramipril was 6-9%. Percentages of maximum ACE inhibitions from baseline were 98.88 (IV ramipril), 5.31 (placebo) and 27.68, 39.27, 46.67, 76.13 and 84.27 (the five doses of PO ramipril). Blood pressure did not change during the experiments. Although oral availability of ramiprilat was low, ramipril has sufficient enteral absorption and bioconversion to ramiprilat to induce serum ACE inhibitions of almost 85% after a dose of 0.80 mg/kg ramipril. Additional research on ramipril administration in equine patients is indicated.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/farmacocinética , Pressão Sanguínea/efeitos dos fármacos , Cavalos/metabolismo , Ramipril/análogos & derivados , Ramipril/farmacologia , Ramipril/farmacocinética , Administração Intravenosa/veterinária , Administração Oral , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Animais , Anti-Hipertensivos/farmacocinética , Anti-Hipertensivos/farmacologia , Relação Dose-Resposta a Droga , Feminino , Masculino , Peptidil Dipeptidase A/sangue
2.
J Vet Intern Med ; 27(6): 1535-42, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24112533

RESUMO

BACKGROUND: Central nervous system blood vessel thrombosis is a part of the pathogenesis of equid herpesvirus-associated myeloencephalopathy (EHM). D-dimers (DD) are stable breakdown products of cross-linked fibrin, and increased DD-plasma concentrations could reflect the degree of systemic coagulation during EHV-1 infection. HYPOTHESIS: We hypothesized that blood DD concentrations will be increased during periods of EHV-1 fever and viremia, reflecting an activated coagulation cascade with fibrinolysis. ANIMALS: Twenty-eight equids were infected with EHV-1 in 3 experimental infection studies. Three (uninfected) horses were included in a separate study to evaluate methodology for DD concentration measurements. METHODS: Clinical data and quantitative viremia were evaluated, and DD concentrations were measured in blood samples on the day before the infection and during days 1-12 postchallenge. Uninfected horses were sampled every 3 hours for 48 hours. Logistic and linear regression was used to investigate the potential association between the fever and viremia with the presence or absence of DD concentrations in peripheral blood. RESULTS: DD concentrations were increased for 1-8 days in the majority of infected animals. Both viremia (odds ratio [OR] 6.3; 95% confidence interval [CI] 3.4-11.8; P = .0013) and fever (OR 4.9; CI 2.3-10.1; P = .001) were strongly associated with the likelihood of detecting DD in peripheral blood. CONCLUSIONS AND CLINICAL IMPORTANCE: EHV-1 viremia is associated with increases in DD concentration in horses and ponies. This indicates that EHV-1 viremia can lead to an activation of coagulation and fibrinolysis.


Assuntos
Produtos de Degradação da Fibrina e do Fibrinogênio/imunologia , Infecções por Herpesviridae/veterinária , Herpesvirus Equídeo 1/imunologia , Doenças dos Cavalos/virologia , Viremia/veterinária , Animais , DNA Viral/química , DNA Viral/genética , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio/análise , Infecções por Herpesviridae/sangue , Infecções por Herpesviridae/imunologia , Infecções por Herpesviridae/virologia , Doenças dos Cavalos/imunologia , Cavalos , Leucócitos Mononucleares , Masculino , Reação em Cadeia da Polimerase/veterinária , Análise de Regressão , Viremia/sangue , Viremia/imunologia , Viremia/virologia
3.
Res Vet Sci ; 95(2): 616-22, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23523471

RESUMO

The influence of hydration prior to exercise on hormonal response to exercise was investigated in horses, divided into two groups, control (n=11) and dehydrated (n=53). They were also classified according to their body weight in A (≈ 350 kg), B (351-450 kg) and C (≈ 451 kg). Horses covered 60 m on a track pulling a carriage loaded with 2, 2.25 and 2.5 times their body weight, for A, B and C. Blood samples were taken at rest, after exercise and during recovery. Electrolytes, albumin, renin, angiotensin and aldosterone concentrations were measured. Dehydrated and control horses had higher aldosterone in category A than B and C. Dehydrated horses presented higher albumin, Na, K, Cl, angiotensin and aldosterone in most of the sampling times. There were no differences in renin associated with body weight category, hydration status and exercise. In dehydration, the response of aldosterone to exercise was higher than in euhydration.


Assuntos
Cavalos/fisiologia , Condicionamento Físico Animal , Sistema Renina-Angiotensina/fisiologia , Animais , Cavalos/sangue , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...